Hypofrontality or reduced activity
Abstract
Hypofrontality or reduced activity in the prefrontal cortex, measured as reduced frontal perfusion or glucose uptake, has gained the status of an established finding in the medical literature on schizophrenia. Many relevant studies, however, have potential sources of bias, such as small subject numbers, or unreliable performance of activation tasks by the patients during the scanning procedure. Seventy patients with non-affective and non-organic psychoses were recruitedmost qualifying for DSM III-R schizophrenia or schizophreniform psychosis (n = 60)-together with 20 healthy volunteers. They underwent single photon emission computed tomography with 99mTc-exametazime, carried out at rest. Tracer uptake was normalised to the occipital cortex. Group differences in tracer uptake were predicted in anterior regions of interest (prefrontal cortex and mesial frontallcingulate cortex). Actively psychotic (including schizophrenic) patients not taking any drugs showed increased uptake in the prefrontal cortex. Reduced tracer uptake occurred in the mesial frontal cortex of schizophrenic patients, particularly if they were taking drugs. Relatively increased prefrontal tracer uptake associated with relatively decreased mesial frontal uptake characterised the patients in comparison with the controls. Generalised hypofrontality is, therefore, not a feature of schizophrenic patients at rest whether taking drugs or not.
Relative frontal hypometabolism (hypofrontality) in schizophrenia was first described 19 years ago by Ingvar and Franzen,' who used an invasive non-tomographic method to determine regional cerebral blood flow with "33Xe in a group of patients with severe chronic illness. Since then, hypofrontality in schizophrenia has achieved the status of a paradigm in neuropsychiatry. In a recent exhaustive review, Andreasen2 found that only half of all functional imaging studies carried out in schizophrenic patients at rest showed hypofrontality. This they explained by the heterogeneity of patient samples.2 In fact, hypofrontality is typically reported in chronically ill patients treated with drugs, ' 3 8 whereas several studies of patients with or without drug treatment have failed to replicate it.9-'4 Drug naive acutely ill patients have even shown the opposite pattern-namely, increased frontal tracer uptake.'5 '9
The second conclusion that can be drawn from recent studies is that activation procedures increase the separation in frontal brain activity between control and schizophrenic groups2 20 Some authors have argued that this is due to the task removing the variability that occurs during the uncontrolled resting state in patients20 and have redefined hypofrontality as "the inability to increase frontal blood flow in response to a frontal stimulus".2 It is doubtful, whether such a redefinition advances our understanding of schizophrenia. The poorer performance of "frontal" activation tasks by patients with schizophrenia is probably sufficient explanation for the difference from controls, who perform such tasks well. Activation hypofrontality may, therefore, tell us more about the functional topology of the task than about schizophrenia.
The emergence of lipophilic blood flow markers, such as technetium-99m labelled hexamethyl-propylenamine oxime (HM-PAO, exametazime), has made it possible to examine large numbers of more representative psychiatric patients. Single photon emission computed tomography (SPECT) with 99mTc-exametazime provides a monotonic measure of regional cerebral blood flow that has been validated in animal and human studies. 16 193537 In the present study we regions of interest. Non-schizophrenic psychotic patients not given drugs showed increased tracer uptake in most prefrontal regions of interest, particularly on the right side (fig 2A) . Schizophrenic patients not treated with drugs showed similar hyperfrontality, pronounced on the right side and in the upper two slices, combined with reduced uptake in the left inferior cingulate cortex ( fig  2B) . Schizophrenic patients treated with drugs showed reductions in frontal areas but these were too small to reach significance. Significant reductions in tracer uptake were seen only in mesial frontal areas ( fig 2G) . The expected hypofrontality in the prefrontal cortex was, therefore, not discernible in this large sample of 40 patients taking drugs. There were no significant correlations between symptom scores or dose of drug and anterior regional tracer uptake in the treated group.
Discussion
Our patients taking drugs showed a reduction in tracer uptake to the mesial frontal-anterior cingulate regions of cerebral cortex. The central finding of this study is, therefore, the dissociation of activity between prefrontal and anterior cingulate structures at rest in psychoses and schizophrenia. Hypofrontality, confined to the anterior cingulate, could also be found in acutely ill patients with DSM-III-R schizophrenia and schizophreniform disorder but not treated with drugs, thereby replicating the results of Tamminga and coworkers.36 By contrast, the prefrontal cortex, the traditional locus of hypofrontality, was overactive in psychotic and schizophrenic patients not given drug treatment, with small non-significant reductions in schizophrenic patients taking drugs.
Global or prefrontal hypofrontality is, therefore, not the robust finding at rest that it is often taken to be in chronic schizophrenia. The common denominator for a diagnosis of schizophrenia instead seems to be a reduction of tracer uptake localised to the mesial frontal and anterior cingulate cortex. It is difficult at present to assess the functional relevance of this underactivity. Pardo et a146 have associated anterior cingulate activation in normal volunteers with performance in the Stroop task, a verbal-visual attention task performed poorly by schizophrenic patients. 47 Furthermore, we have previously examined a patient presenting with right unilateral auditory hallucinations with delusional elaboration in the presence of right hearing impairment and tinnitus with a localised right unilateral anterior cingulate reduction of tracer uptake (AB Doris, RE O'Carroll, KP Ebmeier, unpublished data). The localised reduction in mesial frontal activity can be interpreted, after Frith and Done,48 as reflecting a disruption at a nodal point in the brain monitoring system involved in the supervision of willed actions, that could arguably be the correlate of psychotic experiences in schizophrenia. It is likely not to be the only possible mechanism involved in the generation of psychotic experiences, because the non-schizophrenic patients showed, if anything, cingulate overactivity.
It cannot be entirely excluded that drugs played a part in the anterior reduction of tracer uptake in the treated group, although there were no correlations with dose. It is also impossible to claim primacy for medial frontal involvement in schizophrenia, because this area is closely linked with limbic cortex, prefrontal cortex, and subcortical structures such as the thalamus.
What then is the status of generalised hypofrontality in schizophrenia? Weinberger20 has argued that the failure of resting studies to control for the mental activity of subjects during tracer uptake or wash out is responsible for contradictory results. This explanation is consistent with the recent finding that symptom patterns or syndromes at the time of study are associated with specific regional patterns of resting perfusion-for example, negative symptoms or psychomotor poverty with reduced prefrontal uptake.'94' It might also explain why hyperfrontality in schizophrenic patients has only been described in resting, albeit, actively psychotic patients.'5-'9 The association of psychomotor impairment with prefrontal hypoactivityl9 43 predicts that the extent of hypofrontality is related to patient selection. The original findings with xenon-133 were on extremely retarded, in some cases mute, patients. There was, however, no convincing relation between prefrontal perfusion and psychomotor poverty in our patients treated with drugs. This implies that other factors have contributed to the hypofrontality of other samples. One possibility is that older patients and patients with more severe cognitive deficits may show disproportionate frontal deficits. 49 The complexity of the syndrome we call schizophrenia means that few studies present or control for all the details relevant to the clinical state of different patient groups. The challenge is to isolate those components of the schizophrenia syndrome that can be related reliably to abnormal patterns of brain fimction: the idea that hypofrontality is a central pathophysiological abnormality in schizophrenia does not help us to meet it.
